A 5-month patient with ITP secondary to SARS-CoV-2
Ibrahim Cemal Maslak
Süleyman Demirel University, Pediatric Immunology and Allergy, Isparta, Türkiye
Keywords: SARS-CoV-2, idiopathic thrombocytopenic purpura, intravenous immunoglobulin
Abstract
Idiopathic thrombocytopenic purpura (ITP) is a hematological disease characterized by the immune-mediated destruction of platelets. It either resolves or becomes chronic. Before the onset of ITP, many children have an antecedent viral illness, which can be an upper respiratory infection or gastroenteritis. Regarding ITP frequency, infancy is the least prevalent age group when compared to older children. In this case report, we present the first infantile case of ITP associated with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) that was successfully treated with intravenous immunoglobulin (IVIg).
Cite this article as: Maslak IC. A 5-month patient with ITP secondary to SARS-CoV-2. Pediatr Acad Case Rep. 2022;1(1):13-6.
The authors declared no conflicts of interest with respect to authorship and/or publication of the article.
The authors received no financial support for the research and/or publication of this article.